His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy

Eur Heart J. 1987 Jun;8(6):647-50. doi: 10.1093/oxfordjournals.eurheartj.a062336.

Abstract

His bundle tachycardia is a rare arrhythmia in infants and children and is resistant to therapy. There is now sufficient evidence from reported cases and a further patient reported below to suggest that drug management of this arrhythmia is a reasonable alternative to His bundle ablation with life-long pacing from infancy.

Publication types

  • Case Reports

MeSH terms

  • Amiodarone / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Bundle of His / physiopathology
  • Electrocardiography
  • Flecainide / therapeutic use*
  • Humans
  • Infant, Newborn
  • Male
  • Tachycardia / drug therapy*
  • Tachycardia / physiopathology
  • Verapamil / therapeutic use*

Substances

  • Anti-Arrhythmia Agents
  • Verapamil
  • Flecainide
  • Amiodarone